Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Completed · Phase 3 · Has a placebo group
Conditions studied: Type 2 Diabetes Mellitus
In brief
This was a phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of oral administration of bexagliflozin at 20 mg versus placebo in subjects with T2DM, moderate renal impairment and inadequate glycemic control.
Key facts
- Study ID
- NCT02836873
- Run by
- Theracos
- People needed
- 312
- Starts
- 2016-09-23
- Expected to finish
- 2018-01-11
- Last updated by the study team
- 2021-06-30
Who can join
Age: 20 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — La Palma, California, United States
- Research Site — Lincoln, California, United States
- Research Site — Riverside, California, United States
- Research Site — Sacramento, California, United States
- Research Site — San Dimas, California, United States
- Research Site — Monument, Colorado, United States
- Research Site — Norwalk, Connecticut, United States
- Research Site — Hollywood, Florida, United States
- Research Site — Tampa, Florida, United States
- Research Site — West Palm Beach, Florida, United States
- Research Site — Paducah, Kentucky, United States
- Research Site — Auburn, Maine, United States
- Research Site — Rockport, Maine, United States
- Research Site — Nashua, New Hampshire, United States
- Research Site — The Bronx, New York, United States
- Research Site — Stow, Ohio, United States
- Research Site — Oklahoma City, Oklahoma, United States
- Research Site — Austin, Texas, United States
- Research Site — Austin, Texas, United States
- Research Site — North Richland Hills, Texas, United States
- Research Site — Round Rock, Texas, United States
- Research Site — San Antonio, Texas, United States
- Research Site — Dijon, France
- Research Site — Paris, France
- Research Site — Fresno, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.